Clinical Data submits vilazodone NDA

Clinical Data Inc. (NASDAQ:CLDA) submitted an NDA to FDA for vilazodone to treat major depressive disorder (MDD). Vilazodone is a mixed selective serotonin reuptake inhibitor (SSRI) and partial seroto...